Regeneron Pharmaceuticals, Inc. (BVL:REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions PEN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	201,863	289,053	346,854	293,516	263,568	184,343
Market Cap Growth	-57.15%	-16.66%	18.17%	11.36%	42.98%	35.56%
Enterprise Value	149,915	230,278	298,617	254,323	228,759	172,751
Last Close Price	2090.49	3992.73	-	-	-	-
PE Ratio	12.79	17.37	23.63	17.76	8.18	14.51
PS Ratio	4.01	5.40	7.12	6.33	4.11	6.00
PB Ratio	1.90	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	1.99	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	-	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	-	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	3.01	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	9.50	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	10.81	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	10.99	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.60	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.70	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.38	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.57	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.60	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.34%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.66%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	7.78%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	11.50%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	7.82%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	6.76%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	1.75%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.